PARIS -- Advances in bioresorbable scaffold (BRS) technology suggest a new path for innovation: a hybrid approach borrowing from both conventional metallic stents and fully absorbable scaffolds in ...
SAN DIEGO, CA—Despite no longer being commercially available, clinical data from the Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) continues a disappointing course, leaving ...
PARIS, France—Early data on a handful of new, second-generation bioresorbable scaffold (BRS) devices presented at the EuroPCR 2017 meeting seem to be exciting engineers and clinicians alike, but ...
The Igaki-Tamai® scaffold (Kyoto Medical Planning Co., Ltd, Kyoto, Japan) was the first BRS implanted in humans. It is made of high-molecular-weight poly-L-lactic acid (PLLA) monofilaments (183 kDa) ...
Wilmington, Delaware, United States, June 08, 2023 (GLOBE NEWSWIRE) -- The global bioresorbable vascular scaffold market was valued at USD 161.5 Mn in 2022 and is estimated to surpass USD 316.7 Mn by ...
SEATTLE, UNITED STATES, UNITED STATES, October 7, 2022 / / -- A nonmetallic mesh tube called a bioresorbable vascular scaffold (BVS) is used to treat clogged arteries. It functions similarly to a ...
Bioresorable (also known as bioabsorbable) stents are being held up as a promising alternative to standard drug eluting stents. But there's an internal battle (no pun intended) going on with ...
Please provide your email address to receive an email when new articles are posted on . “Drug-eluting stents reduce the rate of in-stent restenosis, myocardial infarction and target lesion ...
Even with new data, the future of bioresorbable scaffolds remains in flux. At TCT 2018 in September, Reva Medical and Abbott Laboratories painted differing pictures with their respective bioresorbable ...
A second-generation bioresorbable scaffold (BRS) performed angiographically on par with a drug-eluting stent (DES) in the FUTURE-II trial, yet there was little to indicate that this BRS would fare ...
Bioresorbable vascular stents expand the blood vessel to prevent a blockage, which are disintegrated in human body without any external intervention. SEATTLE, WASHINGTON, UNITED STATES, November 15, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results